Tuberculosis Elimination and Laboratory Cooperative Agreement
ID: 352484Type: Posted
Overview

Buyer

Centers for Disease Control - NCHHSTP (HHS-CDC-NCHHSTP)

Award Range

$0 - $0

Eligible Applicants

Unrestricted

Funding Category

Health

Funding Instrument

Cooperative Agreement

Opportunity Category

Discretionary

Cost Sharing or Matching Requirement

Yes

Original Source

https://grants.gov/search-results-detail/352484
Timeline
    Description

    The Centers for Disease Control and Prevention (CDC) is offering a cooperative agreement titled "Tuberculosis Elimination and Laboratory Cooperative Agreement" to support tuberculosis (TB) prevention and control activities at state and local levels. The primary objective of this funding is to enhance public health infrastructure for TB disease surveillance, outbreak response, and laboratory testing, ultimately aiming to reduce TB morbidity and mortality. This initiative is crucial for addressing the public health challenge posed by TB, particularly in areas with high incidence rates, and includes strategies for diagnosis, treatment, epidemiologic surveillance, and public health laboratory strengthening. The estimated total program funding is $374,456,055, with 57 awards expected, and applications must be submitted electronically by September 9, 2024. For further inquiries, interested applicants can contact Martha Boisseau at mboisseau@cdc.gov.

    Point(s) of Contact
    mboisseau@cdc.gov
    Files
    No associated files provided.
    Similar Opportunities
    Innovative Approaches for TB Prevention and Case Finding to END TB
    Active
    Centers for Disease Control and Prevention - ERA
    The Centers for Disease Control and Prevention (CDC) is forecasting a federal grant opportunity titled "Innovative Approaches for TB Prevention and Case Finding to END TB." This initiative aims to develop, implement, and evaluate innovative strategies for tuberculosis (TB) prevention and case finding, focusing on high-burden settings and vulnerable populations, including those living with HIV, children, and economically disadvantaged individuals. The total estimated program funding is $5 million, with an award ceiling of $1 million for up to two cooperative agreements, and applications are expected to be submitted electronically by February 27, 2025. Interested applicants can reach out to Hoang Dang at 404.639.8965 or via email at hdang@cdc.gov for further information.
    Improving prevention, treatment, and care services for HIV and TB for target populations in the Dominican Republic under the President's Emergency Plan for AIDS Relief (PEPFAR)
    Active
    Centers for Disease Control-GHC
    The Centers for Disease Control and Prevention (CDC) is forecasting a cooperative agreement opportunity aimed at improving prevention, treatment, and care services for HIV and tuberculosis (TB) for target populations in the Dominican Republic under the President's Emergency Plan for AIDS Relief (PEPFAR). The initiative focuses on providing high-quality HIV clinical services, particularly for individuals of Haitian descent, by enhancing access to HIV testing, treatment, and TB preventive therapy, while ensuring lifelong retention in care to achieve viral suppression. This funding is crucial for addressing health disparities and improving health outcomes in vulnerable populations, with an estimated total fiscal year funding amount of $5,600,000 for Year 1, and applications are expected to be submitted electronically by February 17, 2025. Interested applicants can reach out to Emily Dale at (404) 639-8880 or via email at pepfarfoas@cdc.gov for further information.
    Reducing the burden of parasitic infections in the United States through evidence-based prevention and control activities
    Active
    Centers for Disease Control - NCEZID
    The Centers for Disease Control and Prevention (CDC) is forecasting a federal grant opportunity aimed at reducing the burden of parasitic infections in the United States through evidence-based prevention and control activities. This initiative, structured as a cooperative agreement, focuses on three key components: enhancing healthcare provider knowledge and practices regarding Chagas disease, expanding public health surveillance for soil-transmitted helminths, and addressing other significant parasitic diseases of domestic concern. With an estimated total program funding of $10 million and an award ceiling of $1 million, the CDC anticipates making approximately seven awards, with applications due by May 2, 2025. Interested applicants can reach out to Emily Dodd at 404-639-3753 or via email at iog2@cdc.gov for further information.
    Tanzania Global Health Security Partner Engagement: Advancing Efforts and Strategies to Protect and Improve Public Health
    Active
    Centers for Disease Control-GHC
    The Centers for Disease Control and Prevention (CDC) is forecasting a cooperative agreement opportunity titled "Tanzania Global Health Security Partner Engagement: Advancing Efforts and Strategies to Protect and Improve Public Health." This initiative aims to support the Tanzanian government in fulfilling key International Health Regulations requirements through the implementation of the Global Health Security Agenda, focusing on areas such as biosurveillance systems, emergency capacity expansion, laboratory capabilities, disease reporting, and workforce development. The total estimated program funding is $5 million, with four awards expected, and applications must be submitted electronically by January 1, 2025, with an anticipated award date of September 30, 2025. For further inquiries, interested applicants can contact Shana Eatman at 770.488.3933 or via email at DGHPNOFOs@cdc.gov.
    Sustaining HIV and TB epidemic control in Lesotho through health system strengthening and technical assistance under the President's Emergency Plan for AIDS Relief (PEPFAR)
    Active
    Centers for Disease Control-GHC
    The Centers for Disease Control and Prevention (CDC) is forecasting a federal grant opportunity titled "Sustaining HIV and TB epidemic control in Lesotho through health system strengthening and technical assistance under the President's Emergency Plan for AIDS Relief (PEPFAR)." The primary objective of this cooperative agreement is to accelerate and sustain HIV epidemic control while reducing TB incidence by implementing evidence-based interventions and innovative strategies in the districts of Leribe, Berea, Quthing, and Qacha’s Nek, in collaboration with the Ministry of Health. This initiative is crucial for achieving the UNAIDS 95-95-95 targets and aligns with PEPFAR's strategic direction to eliminate HIV/AIDS as a public health threat while strengthening the public health system sustainably. Interested applicants can expect an estimated total funding amount of $15 million for the first fiscal year, with applications due by February 17, 2025, and should contact Emily Dale at (404) 639-8880 or via email at pepfarfoas@cdc.gov for further information.
    RFA-CC-18-000
    Active
    Centers for Disease Control and Prevention - ERA
    The Centers for Disease Control and Prevention (CDC) is offering a federal grant opportunity titled RFA-CC-18-000, aimed at supporting Type 6 Applications through cooperative agreements. Eligible applicants include states, universities, counties, small businesses, and non-profit organizations, with no cost-sharing or matching requirements specified. This funding initiative is categorized under health-related activities, with an expected total of 100 awards available, although the award ceiling and floor are both set at zero. Interested parties should note that the application deadline is October 13, 2025, and may contact Linton C. Browning at lbrowning@cdc.gov or by phone at 770-488-2756 for further information.
    RFA-TS-18-000
    Active
    Centers for Disease Control and Prevention - ERA
    The Centers for Disease Control and Prevention (CDC) is offering a federal grant opportunity titled RFA-TS-18-000, aimed at supporting various health-related initiatives through cooperative agreements. Eligible applicants include states, universities, counties, small businesses, and non-profit organizations, with the program designed to facilitate Type 6 Applications as necessary. This funding opportunity is significant for enhancing public health efforts, with an expected total of 100 awards available, although no specific funding amounts are indicated. Interested parties should note that applications are due by October 13, 2025, and can direct inquiries to Linton C Browning at lbrowning@cdc.gov or by phone at 770-488-2756.
    Strengthening Multisectoral Global Laboratory Systems to Safely and Accurately Mitigate Bio Risks, Deploy Diagnostics and Sequence Pathogens to Detect, Prevent and Respond to Global Health Threats
    Active
    Centers for Disease Control-GHC
    The Centers for Disease Control and Prevention (CDC) is forecasting a cooperative agreement opportunity titled "Strengthening Multisectoral Global Laboratory Systems to Safely and Accurately Mitigate Bio Risks, Deploy Diagnostics and Sequence Pathogens to Detect, Prevent and Respond to Global Health Threats." This initiative aims to enhance global public health by strengthening laboratory systems, improving workforce capabilities, managing bio risks, and enhancing diagnostic capacities, particularly in low-resource settings. The program is critical for reinforcing emergency laboratory preparedness and ensuring effective responses to global health threats, with an estimated total funding of $25 million available for approximately five awards. Interested applicants can reach out to Shana Eatman at 770.488.3933 or via email at DGHPNOFOs@cdc.gov, with applications due by January 1, 2025, and awards expected to be announced by September 30, 2025.
    RFA-TP-18-000
    Active
    Centers for Disease Control and Prevention - ERA
    The Centers for Disease Control and Prevention (CDC) is offering a federal grant opportunity titled RFA-TP-18-000, aimed at supporting various entities, including states, universities, small businesses, and non-profit organizations, through a cooperative agreement in the health sector. Applicants are invited to submit Type 6 Applications as necessary, with the expectation of awarding approximately 100 grants under this program. This initiative is crucial for enhancing public health efforts and addressing health-related challenges across diverse communities. Interested applicants should note that there is no cost-sharing requirement, and the application deadline is set for October 13, 2025. For further inquiries, contact Linton C. Browning at lbrowning@cdc.gov or by phone at 770-488-2756.
    Halting Tuberculosis (TB) Transmission (R01 Clinical Trial Optional)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a funding opportunity titled "Halting Tuberculosis (TB) Transmission," aimed at understanding and addressing the critical drivers of TB transmission in high-burden settings. The initiative seeks to develop effective measurement methods and assess potential low-cost interventions to prevent TB transmission, with a particular focus on the role of asymptomatic TB and leveraging insights from COVID-19 research. A total of $6 million is anticipated for FY 2025 to fund 4-5 awards, with each application budget capped at $750,000 per year over a maximum project period of 5 years. Eligible applicants include a diverse range of organizations, and interested parties can find more information and submission details at the provided NIH link, with applications due by December 4, 2024.